v3.25.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
Collaboration revenue $ 13,631 $ 63,533
Type of Revenue [Extensible List] us-gaap:LicenseMember us-gaap:LicenseMember
Operating expenses:    
Research and development $ 135,001 $ 172,596
General and administrative 74,169 81,448
Impairment loss 14,737 0
Total operating expenses 223,907 254,044
Loss from operations (210,276) (190,511)
Other income:    
Interest income 17,288 17,186
Change in fair value of stock price appreciation milestones 819 2,515
Other income 5,907 9,882
Total other income 24,014 29,583
Net loss (186,262) (160,928)
Other comprehensive gain:    
Unrealized gain on available-for-sale securities, net 253 1,869
Comprehensive loss $ (186,009) $ (159,059)
Net loss per share, Basic $ (1.64) $ (1.64)
Net loss per share, Diluted $ (1.64) $ (1.64)
Weighted-average common shares used to compute basic net loss per share 113,685,177 98,411,162
Weighted-average common shares used to compute diluted net loss per share 113,685,177 98,411,162